Activated Protein C and Microcirculation

计划入组 22 人 · 首次发布于 2013 年 3 月 7 日

Efficacy and Safety Study of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency

计划入组 18 人 · 首次发布于 2005 年 9 月 12 日

Activated Protein C in Severe Acute Pancreatitis

计划入组 32 人 · 首次发布于 2009 年 11 月 20 日

Protein C(Balfaxar, Beriplex, Ceprotin, Kcentra, Octaplex)

Protein C activated (Bioatrix)

c-MYC protein inhibitor (cancer)

Protein Sciences Corporation

United States

C & C Oxygen Company

United States

Buchanan C Michael

United States

Tenaya Therapeutics' TN-201 Shows Promise in Early Hypertrophic Cardiomyopathy Trial

FDA Lifts Clinical Hold on Tenaya's TN-201 Gene Therapy for Genetic Heart Disease

Tenaya Therapeutics Reveals Critical Risk Factors in Largest Pediatric MYBPC3-Associated HCM Study